US7819837B2 - Device for controlling flow rate of aspirated fluids - Google Patents

Device for controlling flow rate of aspirated fluids Download PDF

Info

Publication number
US7819837B2
US7819837B2 US12/332,782 US33278208A US7819837B2 US 7819837 B2 US7819837 B2 US 7819837B2 US 33278208 A US33278208 A US 33278208A US 7819837 B2 US7819837 B2 US 7819837B2
Authority
US
United States
Prior art keywords
motor
pump
chamber
rotor
rotors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US12/332,782
Other versions
US20100152656A1 (en
Inventor
Douglas E. Music
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Priority to US12/332,782 priority Critical patent/US7819837B2/en
Assigned to BAUSCH & LOMB INCORPORATED reassignment BAUSCH & LOMB INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MUSIC, DOUGLAS E.
Priority to EP09771819.1A priority patent/EP2379029B1/en
Priority to HK12101494.5A priority patent/HK1160758B/en
Priority to CA2745217A priority patent/CA2745217C/en
Priority to PCT/US2009/067065 priority patent/WO2010068611A1/en
Priority to ES09771819T priority patent/ES2406806T3/en
Priority to CN2009801499048A priority patent/CN102245140B/en
Priority to JP2011540812A priority patent/JP2012511957A/en
Publication of US20100152656A1 publication Critical patent/US20100152656A1/en
Publication of US7819837B2 publication Critical patent/US7819837B2/en
Application granted granted Critical
Assigned to CREDIT SUISSE AG, AS ADMINISTRATIVE AGENT reassignment CREDIT SUISSE AG, AS ADMINISTRATIVE AGENT SECURITY AGREEMENT Assignors: BAUSCH & LOMB INCORPORATED, WP PRISM INC.
Assigned to BAUSCH & LOMB INCORPORATED reassignment BAUSCH & LOMB INCORPORATED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Assigned to CITIBANK N.A., AS ADMINISTRATIVE AGENT reassignment CITIBANK N.A., AS ADMINISTRATIVE AGENT SECURITY AGREEMENT Assignors: BAUSCH & LOMB INCORPORATED, EYEONICS, INC.
Assigned to BAUSCH & LOMB INCORPORATED, ISTA PHARMACEUTICALS, WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.) reassignment BAUSCH & LOMB INCORPORATED RELEASE OF SECURITY INTEREST Assignors: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Assigned to GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT reassignment GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: BAUSCH & LOMB INCORPORATED
Assigned to BARCLAYS BANK PLC, AS SUCCESSOR AGENT reassignment BARCLAYS BANK PLC, AS SUCCESSOR AGENT NOTICE OF SUCCESSION OF AGENCY Assignors: GOLDMAN SACHS LENDING PARTNERS, LLC
Assigned to SALIX PHARMACEUTICALS, INC., Salix Pharmaceuticals, Ltd, BAUSCH HEALTH HOLDCO LIMITED, PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.), ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.), SOLTA MEDICAL, INC., BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA), V-BAC HOLDING CORP., PRECISION DERMATOLOGY, INC., ORAPHARMA, INC., BAUSCH & LOMB MEXICO, S.A. DE C.V., VRX HOLDCO LLC, 1261229 B.C. LTD., MEDICIS PHARMACEUTICAL CORPORATION, BAUSCH+LOMB OPS B.V., BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED), SOLTA MEDICAL IRELAND LIMITED, SOLTA MEDICAL DUTCH HOLDINGS B.V., BAUSCH HEALTH US, LLC, SANTARUS, INC., BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC), BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC., 1530065 B.C. LTD., HUMAX PHARMACEUTICAL S.A., BAUSCH HEALTH COMPANIES INC. reassignment SALIX PHARMACEUTICALS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71—Suction drainage systems
    • A61M1/77—Suction-irrigation systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/80—Suction pumps

Definitions

  • the present disclosure relates to control of fluid flow into and out of a surgical site, and more particularly to the control of aspirated fluid flow in ophthalmic microsurgical systems.
  • a surgeon may introduce the flow of fluids into an operative site in an eye, and fluids may be aspirated from the operative site utilizing flow control devices for collecting aspirated fluids.
  • flow control devices for collecting aspirated fluids.
  • the introduction of fluids and application of vacuum for aspirating fluids from the eye may accordingly pose certain risks.
  • aspiration flow rate is difficult to measure or to timely infer from the vacuum level.
  • changes in the vacuum applied, the aspiration flow rate and the infusion fluid pressure and flow rate may result in pressure variations within the eye. This makes the control of intraocular pressure and fluid flow into and out of the eye very desirable.
  • a flow control device for balancing fluid flow into and out of a surgical site, especially an eye.
  • a flow control device includes a housing having a motor chamber and a pump chamber.
  • the motor chamber has an outlet in communication with a fluid collection device, and an inlet in communication with an aspiration line through which fluids are delivered into the motor chamber.
  • First and second motor rotors are rotatably disposed in the flow path between the inlet and the outlet in the motor chamber. At least one motor rotor is coupled to the end of a drive shaft.
  • the pump chamber has an outlet for infusing fluid to a surgical site, and an inlet through which infusion fluids are delivered into the pump chamber.
  • First and second pump rotors are rotatably disposed in the flow path between the inlet and the outlet in the pump chamber.
  • At least one pump rotor is coupled to a drive shaft that is also coupled to a motor rotor.
  • the drive shaft drives the pump rotor at the same speed as the motor rotor, such that any surge in aspiration flow induces a similar surge in infusion flow.
  • FIG. 1 is a perspective cut-away view of one embodiment of a flow control device for balancing fluid flow into and out of a surgical site, in accordance with the principles of the present disclosure
  • FIG. 2 is a perspective cut-away view of a second embodiment of a flow control device for balancing fluid flow into and out of a surgical site, in accordance with the principles of the present disclosure.
  • a flow control device for balancing fluid flow into and out of a surgical site, such as an eye.
  • Ophthalmic microsurgery systems typically supply an aspirant fluid, such as a balanced salt solution (BSS), for example, to a surgical site via an infusion line. Fluids are typically aspirated from the surgical site through an aspiration line, which may be connected to a fluid collection cassette or collection bag.
  • Ophthalmic microsurgery systems may employ a vacuum or other suitable aspiration source in communication with the aspiration line to establish a vacuum for urging the aspiration of fluid from a surgical site.
  • a flow sensor may also be used in an attempt to monitor the rate that fluid is being aspirated from the surgical site.
  • any surge in the aspiration flow due to a change in vacuum level will result in a change in the intraocular eye pressure, which could cause trauma or injury to the eye.
  • any surge in the infusion line will result in an increase in the intraocular eye pressure, which could cause trauma or injury to the eye.
  • a flow control device 100 is configured to be placed in line with and connected to an aspiration line, and also in line with and connected to an infusion line to the surgical site.
  • the flow control device 100 is preferably positioned in the infusion and aspiration lines proximal to a surgical handpiece for regulating fluid flow. It is also possible that flow control device 100 could be incorporated with a surgical handpiece, such that the flow control device can be placed very close to the surgical site.
  • the infusion fluid flow into the eye and the aspiration fluid flow out of an eye is regulated or controlled by the flow control device 100 , to thereby prevent any surge-induced pressure changes that could affect the intraocular eye pressure in the eye.
  • the aspiration flow control device includes a housing having a motor chamber and a pump chamber.
  • the motor chamber has an outlet in communication with a fluid collection device, and an inlet in communication with an aspiration line through which fluids are delivered into the motor chamber.
  • First and second motor rotors are rotatably disposed in the flow path between the inlet and the outlet in the motor chamber. At least one motor rotor is coupled to the end of a drive shaft.
  • the pump chamber has an outlet for infusing fluid to a surgical site, and an inlet through which infusion fluids are delivered into the pump chamber.
  • First and second pump rotors are rotatably disposed in the flow path between the inlet and the outlet in the pump chamber.
  • At least one pump rotor is coupled to a drive shaft that is coupled to a motor rotor.
  • the drive shaft drives the pump rotor at the same speed as the motor rotor, such that any surge in aspiration flow induces a similar surge in infusion flow.
  • the fluid flow balancing device 100 includes a housing 102 having a motor chamber 110 and a pump chamber 120 that are disposed within the housing 102 adjacent each other.
  • the motor chamber 110 has an outlet 112 for communication with a fluid collection device or vacuum source (not shown) via an aspiration line (also not shown), and an inlet 114 for communication with an aspiration line or outlet of a surgical handpiece through which fluids from a surgical site are delivered to the motor chamber 110 .
  • the pump chamber 120 has an outlet 124 for communication with an infusion line or inlet of a surgical handpiece (not shown) for supplying fluid to a surgical site, and an inlet 122 for attachment to an infusion line through which infusion fluids are delivered to the pump chamber 120 .
  • the inlet and outlet to the motor chamber 110 and the inlet and outlet to the pump chamber 120 may further comprise a tubing barb configured for connection with known surgical tubing.
  • a first motor rotor 116 and a second motor rotor 118 are rotatably disposed within the motor chamber 110 , and positioned in the flow path 115 between the inlet 114 and the outlet 112 in the motor chamber 110 .
  • the first motor rotor 116 and second motor rotor 118 are positioned relative to each other such that at least one rotor blade 119 of both motor rotors overlap in the region of a flow path 115 between the inlet 114 and the outlet 112 .
  • a first pump rotor 126 and a second pump rotor 128 are rotatably disposed within the pump chamber 120 , and positioned in an infusion flow path 125 between an inlet 122 and an outlet 124 in the pump chamber 120 .
  • the first pump rotor 126 and second pump rotor 128 are positioned relative to each other such that at least one rotor blade 129 of both pump rotors overlap in the region of the flow path 125 between the inlet 122 and the outlet 124 of the pump chamber 120 .
  • the flow control device 100 further includes a drive shaft 130 having a first end coupled to the first motor rotor 116 and a second end coupled to the first pump rotor 126 . Fluid flowing between the inlet 114 and outlet 112 of the motor chamber 110 cause the first motor rotor 116 to rotate the drive shaft 130 .
  • the drive shaft 130 drives the first pump rotor 126 at the same rotational speed as the first motor rotor 116 , such that any surge in aspiration fluid flow through the motor chamber 110 induces a similar surge in infusion fluid flow through the pump chamber 120 . This accordingly reduces the risk of surge-induced pressure changes in the operative site.
  • any restriction that reduces the rate of aspirated fluid flow through the motor chamber 110 will reduce the speed of the pump rotors 126 and 128 , to thereby reduce the risk of over-pressure in the operative site.
  • the first and second motor rotors 116 and 118 are arranged generally parallel with the first and second pump rotors 126 and 128 . Additionally, the first motor rotor 116 and first pump rotor 126 are axially aligned, and the second motor rotor 118 and second pump rotor 128 are axially aligned. Both the motor rotors 116 , 118 and pump rotors 126 , 128 are comprised of a generally paddle-wheel shaped configuration. In both the motor rotors 116 , 118 and pump rotors 126 and 128 , the overlap between the first rotor blades and second rotor blades results in the first and second rotors rotating at substantially the same rotational speed.
  • the motor rotors 116 and 118 act similarly to a turbine within a rotary engine, and are used to extract energy from a fluid flow 115 that flows past the motor rotors.
  • the energy extracted from the fluid flow results in the rotation of the motor rotor 116 , and the rotation of drive shaft 130 .
  • the first and second motor rotors 116 and 118 overlap in the region of the flow path (e.g.—their rotor blades overlap and contact each other), the first and second motor rotor blades each rotate at substantially the same rotational speed (rotations per minute).
  • the fluid within the motor chamber 110 provides some resistance to the rotation of the motor rotors 116 and 118 , which slows the rotor rotation. This reduced rotation in turn reduces the rotation of the pump rotors, to thereby reduce the flow of infusion fluid to the operative site and lessen the risk of unwanted increased intraocular pressure in the eye being operated on.
  • the flow control device 100 may optionally include a bypass valve (not shown) on the pump stage that allows volume flow of infusion fluids to the operation site unrestricted by the rotors.
  • FIG. 1 shows the motor rotors 116 and 118 positioned to overlap each other in the region of the flow path 115 that impinges on the rotor blades 119
  • the rotor blades 119 may not overlap each other.
  • the rotors may be sufficiently spaced apart so that the rotor blades cannot contact each other, but positioned such that each rotor extends equally into the region of the flow path that impinges on the rotor blades.
  • first motor rotor 216 and second motor rotor 218 are respectively coupled to a first drive shaft 230 and a second drive shaft 232 , where the first and second drive shafts are further coupled to first and second pump rotors 226 and 228 .
  • the fluid flow 215 impinging on the motor rotor blades cause the motor rotors 216 and 218 to rotate, where each motor rotor rotates a corresponding drive shaft 230 or 232 .
  • the motor rotor blades 219 and pump rotor blades 229 may not overlap with each other.
  • the alternate embodiment shown in FIG. 2 comprises a housing 202 having a motor chamber 210 and a pump chamber 220 disposed therein, with two drive shafts 230 and 232 extending therebetween.
  • the motor chamber 210 has an outlet 212 in communication with a fluid collection device (not shown), and an inlet 214 in communication with an aspiration line through which fluids from a surgical site are delivered to the motor chamber 210 .
  • the pump chamber 220 has an outlet 224 in communication with an infusion line (not shown) for supplying fluid to a surgical site, and an inlet 222 through which infusion fluids are delivered to the pump chamber 220 .
  • a first motor rotor 216 and a second motor rotor 218 are rotatably disposed within the motor chamber 210 , and positioned in the flow path 215 between the inlet 214 and the outlet 212 in the motor chamber 210 .
  • a first pump rotor 226 and a second pump rotor 228 are rotatably disposed within the pump chamber 220 , and positioned in the flow path 225 between the inlet 222 and the outlet 224 in the pump chamber 220 .
  • a first drive shaft 230 has one end coupled to the first motor rotor 216 and an opposite end coupled to the first pump rotor 226 .
  • a second drive shaft 232 has a one end coupled to the second motor rotor 218 and an opposite end coupled to the second pump rotor 228 . Fluid flowing between the inlet 214 and outlet 212 of the motor chamber 210 causes the first and second motor rotors 216 and 218 to rotate the first and second drive shafts 230 and 232 .
  • Each drive shaft 230 and 232 drives its pump rotor at the same rotational speed as the respectively coupled motor rotor, such that any surge in aspiration fluid flow through the motor chamber induces a similar surge in infusion fluid flow, to thereby reduce the risk of surge-induced pressure changes in the operative site.
  • the present invention provides an improvement to aspiration fluid flow control, to thereby control the flow rate of fluid aspirated from a surgical site.
  • the present invention is illustrated herein by example, and various modifications may be made by a person of ordinary skill in the art. It is believed that the operation and construction of the present invention will be apparent from the foregoing description. While the apparatus and methods shown or described above have been characterized as being preferred, various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined in the following claims.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • External Artificial Organs (AREA)

Abstract

A flow control device includes a housing having a motor chamber and a pump chamber. The motor chamber has an outlet for communication with a fluid collection device, and an inlet for communication with an aspiration line through which fluids are delivered into the motor chamber. First and second motor rotors are rotatably disposed in a flow path between the inlet and the outlet in the motor chamber, and a drive shaft is coupled to the first motor rotor. The pump chamber has an outlet for infusing fluid to a surgical site, and an inlet through which infusion fluids are delivered into the pump chamber. First and second pump rotors are rotatably disposed in a flow path between the inlet and the outlet in the pump chamber, where the first pump rotor is coupled to the drive shaft. The drive shaft drives the pump rotors at the same speed as the motor rotors, such that any surge in aspiration flow induces a similar surge in infusion flow.

Description

FIELD
The present disclosure relates to control of fluid flow into and out of a surgical site, and more particularly to the control of aspirated fluid flow in ophthalmic microsurgical systems.
BACKGROUND
This section provides background information related to the present disclosure which is not necessarily prior art.
During ophthalmic microsurgery, a surgeon may introduce the flow of fluids into an operative site in an eye, and fluids may be aspirated from the operative site utilizing flow control devices for collecting aspirated fluids. However, it is important to prevent over-pressurizing or collapsing the eye to avoid trauma to the retina. The introduction of fluids and application of vacuum for aspirating fluids from the eye may accordingly pose certain risks. However, where vacuum-based systems are employed, aspiration flow rate is difficult to measure or to timely infer from the vacuum level. Additionally, changes in the vacuum applied, the aspiration flow rate and the infusion fluid pressure and flow rate may result in pressure variations within the eye. This makes the control of intraocular pressure and fluid flow into and out of the eye very desirable.
SUMMARY
This section provides a general summary of the disclosure, and is not a comprehensive disclosure of its full scope or all of its features. The present disclosure relates to a flow control device for balancing fluid flow into and out of a surgical site, especially an eye. According to one aspect of the present disclosure, a flow control device includes a housing having a motor chamber and a pump chamber. The motor chamber has an outlet in communication with a fluid collection device, and an inlet in communication with an aspiration line through which fluids are delivered into the motor chamber. First and second motor rotors are rotatably disposed in the flow path between the inlet and the outlet in the motor chamber. At least one motor rotor is coupled to the end of a drive shaft. The pump chamber has an outlet for infusing fluid to a surgical site, and an inlet through which infusion fluids are delivered into the pump chamber. First and second pump rotors are rotatably disposed in the flow path between the inlet and the outlet in the pump chamber. At least one pump rotor is coupled to a drive shaft that is also coupled to a motor rotor. The drive shaft drives the pump rotor at the same speed as the motor rotor, such that any surge in aspiration flow induces a similar surge in infusion flow.
Further areas of applicability will become apparent from the description provided herein. The description and specific examples in this summary are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.
BRIEF DESCRIPTION OF THE DRAWINGS
The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.
FIG. 1 is a perspective cut-away view of one embodiment of a flow control device for balancing fluid flow into and out of a surgical site, in accordance with the principles of the present disclosure; and
FIG. 2 is a perspective cut-away view of a second embodiment of a flow control device for balancing fluid flow into and out of a surgical site, in accordance with the principles of the present disclosure.
Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.
DETAILED DESCRIPTION
Example embodiments will now be described more fully with reference to the accompanying drawings. The foregoing description of the embodiments has been provided for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention. Individual elements or features of a particular embodiment are generally not limited to that particular embodiment, but, where applicable, are interchangeable and can be used in a selected embodiment, even if not specifically shown or described. The same may also be varied in many ways. Such variations are not to be regarded as a departure from the invention, and all such modifications are intended to be included within the scope of the invention.
In the various embodiments, a flow control device is provided for balancing fluid flow into and out of a surgical site, such as an eye. Ophthalmic microsurgery systems typically supply an aspirant fluid, such as a balanced salt solution (BSS), for example, to a surgical site via an infusion line. Fluids are typically aspirated from the surgical site through an aspiration line, which may be connected to a fluid collection cassette or collection bag. Ophthalmic microsurgery systems may employ a vacuum or other suitable aspiration source in communication with the aspiration line to establish a vacuum for urging the aspiration of fluid from a surgical site. A flow sensor may also be used in an attempt to monitor the rate that fluid is being aspirated from the surgical site. However, any surge in the aspiration flow due to a change in vacuum level will result in a change in the intraocular eye pressure, which could cause trauma or injury to the eye. Similarly, any surge in the infusion line will result in an increase in the intraocular eye pressure, which could cause trauma or injury to the eye.
To address these concerns, a flow control device 100 is configured to be placed in line with and connected to an aspiration line, and also in line with and connected to an infusion line to the surgical site. The flow control device 100 is preferably positioned in the infusion and aspiration lines proximal to a surgical handpiece for regulating fluid flow. It is also possible that flow control device 100 could be incorporated with a surgical handpiece, such that the flow control device can be placed very close to the surgical site. The infusion fluid flow into the eye and the aspiration fluid flow out of an eye is regulated or controlled by the flow control device 100, to thereby prevent any surge-induced pressure changes that could affect the intraocular eye pressure in the eye.
Generally, the aspiration flow control device includes a housing having a motor chamber and a pump chamber. The motor chamber has an outlet in communication with a fluid collection device, and an inlet in communication with an aspiration line through which fluids are delivered into the motor chamber. First and second motor rotors are rotatably disposed in the flow path between the inlet and the outlet in the motor chamber. At least one motor rotor is coupled to the end of a drive shaft. The pump chamber has an outlet for infusing fluid to a surgical site, and an inlet through which infusion fluids are delivered into the pump chamber. First and second pump rotors are rotatably disposed in the flow path between the inlet and the outlet in the pump chamber. At least one pump rotor is coupled to a drive shaft that is coupled to a motor rotor. The drive shaft drives the pump rotor at the same speed as the motor rotor, such that any surge in aspiration flow induces a similar surge in infusion flow.
Referring to FIG. 1, one embodiment of a fluid flow control device 100 for providing balanced fluid flow into and out of a surgical site is shown. As shown in FIG. 1, the fluid flow balancing device 100 includes a housing 102 having a motor chamber 110 and a pump chamber 120 that are disposed within the housing 102 adjacent each other. The motor chamber 110 has an outlet 112 for communication with a fluid collection device or vacuum source (not shown) via an aspiration line (also not shown), and an inlet 114 for communication with an aspiration line or outlet of a surgical handpiece through which fluids from a surgical site are delivered to the motor chamber 110. The pump chamber 120 has an outlet 124 for communication with an infusion line or inlet of a surgical handpiece (not shown) for supplying fluid to a surgical site, and an inlet 122 for attachment to an infusion line through which infusion fluids are delivered to the pump chamber 120. The inlet and outlet to the motor chamber 110 and the inlet and outlet to the pump chamber 120 may further comprise a tubing barb configured for connection with known surgical tubing.
A first motor rotor 116 and a second motor rotor 118 are rotatably disposed within the motor chamber 110, and positioned in the flow path 115 between the inlet 114 and the outlet 112 in the motor chamber 110. The first motor rotor 116 and second motor rotor 118 are positioned relative to each other such that at least one rotor blade 119 of both motor rotors overlap in the region of a flow path 115 between the inlet 114 and the outlet 112.
A first pump rotor 126 and a second pump rotor 128 are rotatably disposed within the pump chamber 120, and positioned in an infusion flow path 125 between an inlet 122 and an outlet 124 in the pump chamber 120. The first pump rotor 126 and second pump rotor 128 are positioned relative to each other such that at least one rotor blade 129 of both pump rotors overlap in the region of the flow path 125 between the inlet 122 and the outlet 124 of the pump chamber 120.
The flow control device 100 further includes a drive shaft 130 having a first end coupled to the first motor rotor 116 and a second end coupled to the first pump rotor 126. Fluid flowing between the inlet 114 and outlet 112 of the motor chamber 110 cause the first motor rotor 116 to rotate the drive shaft 130. The drive shaft 130 drives the first pump rotor 126 at the same rotational speed as the first motor rotor 116, such that any surge in aspiration fluid flow through the motor chamber 110 induces a similar surge in infusion fluid flow through the pump chamber 120. This accordingly reduces the risk of surge-induced pressure changes in the operative site. Similarly, any restriction that reduces the rate of aspirated fluid flow through the motor chamber 110 will reduce the speed of the pump rotors 126 and 128, to thereby reduce the risk of over-pressure in the operative site.
As shown in FIG. 1, the first and second motor rotors 116 and 118 are arranged generally parallel with the first and second pump rotors 126 and 128. Additionally, the first motor rotor 116 and first pump rotor 126 are axially aligned, and the second motor rotor 118 and second pump rotor 128 are axially aligned. Both the motor rotors 116, 118 and pump rotors 126, 128 are comprised of a generally paddle-wheel shaped configuration. In both the motor rotors 116, 118 and pump rotors 126 and 128, the overlap between the first rotor blades and second rotor blades results in the first and second rotors rotating at substantially the same rotational speed.
In operation, the motor rotors 116 and 118 act similarly to a turbine within a rotary engine, and are used to extract energy from a fluid flow 115 that flows past the motor rotors. The energy extracted from the fluid flow results in the rotation of the motor rotor 116, and the rotation of drive shaft 130. Because the first and second motor rotors 116 and 118 overlap in the region of the flow path (e.g.—their rotor blades overlap and contact each other), the first and second motor rotor blades each rotate at substantially the same rotational speed (rotations per minute). Similarly, when a decrease in the rate of aspirated fluid flow through the motor chamber 110 occurs, the fluid within the motor chamber 110 provides some resistance to the rotation of the motor rotors 116 and 118, which slows the rotor rotation. This reduced rotation in turn reduces the rotation of the pump rotors, to thereby reduce the flow of infusion fluid to the operative site and lessen the risk of unwanted increased intraocular pressure in the eye being operated on. The flow control device 100 may optionally include a bypass valve (not shown) on the pump stage that allows volume flow of infusion fluids to the operation site unrestricted by the rotors.
While FIG. 1 shows the motor rotors 116 and 118 positioned to overlap each other in the region of the flow path 115 that impinges on the rotor blades 119, in an alternate construction or embodiment, the rotor blades 119 may not overlap each other. For example, the rotors may be sufficiently spaced apart so that the rotor blades cannot contact each other, but positioned such that each rotor extends equally into the region of the flow path that impinges on the rotor blades.
In one alternate embodiment shown in FIG. 2, the first motor rotor 216 and second motor rotor 218 are respectively coupled to a first drive shaft 230 and a second drive shaft 232, where the first and second drive shafts are further coupled to first and second pump rotors 226 and 228. The fluid flow 215 impinging on the motor rotor blades cause the motor rotors 216 and 218 to rotate, where each motor rotor rotates a corresponding drive shaft 230 or 232. In this alternate construction, the motor rotor blades 219 and pump rotor blades 229 may not overlap with each other.
The alternate embodiment shown in FIG. 2 comprises a housing 202 having a motor chamber 210 and a pump chamber 220 disposed therein, with two drive shafts 230 and 232 extending therebetween. The motor chamber 210 has an outlet 212 in communication with a fluid collection device (not shown), and an inlet 214 in communication with an aspiration line through which fluids from a surgical site are delivered to the motor chamber 210. The pump chamber 220 has an outlet 224 in communication with an infusion line (not shown) for supplying fluid to a surgical site, and an inlet 222 through which infusion fluids are delivered to the pump chamber 220. A first motor rotor 216 and a second motor rotor 218 are rotatably disposed within the motor chamber 210, and positioned in the flow path 215 between the inlet 214 and the outlet 212 in the motor chamber 210. A first pump rotor 226 and a second pump rotor 228 are rotatably disposed within the pump chamber 220, and positioned in the flow path 225 between the inlet 222 and the outlet 224 in the pump chamber 220. A first drive shaft 230 has one end coupled to the first motor rotor 216 and an opposite end coupled to the first pump rotor 226. A second drive shaft 232 has a one end coupled to the second motor rotor 218 and an opposite end coupled to the second pump rotor 228. Fluid flowing between the inlet 214 and outlet 212 of the motor chamber 210 causes the first and second motor rotors 216 and 218 to rotate the first and second drive shafts 230 and 232. Each drive shaft 230 and 232 drives its pump rotor at the same rotational speed as the respectively coupled motor rotor, such that any surge in aspiration fluid flow through the motor chamber induces a similar surge in infusion fluid flow, to thereby reduce the risk of surge-induced pressure changes in the operative site.
From the above, it may be appreciated that the present invention provides an improvement to aspiration fluid flow control, to thereby control the flow rate of fluid aspirated from a surgical site. The present invention is illustrated herein by example, and various modifications may be made by a person of ordinary skill in the art. It is believed that the operation and construction of the present invention will be apparent from the foregoing description. While the apparatus and methods shown or described above have been characterized as being preferred, various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined in the following claims.

Claims (17)

1. An ophthalmic surgical flow control device for balancing fluid flow into and out of a surgical site, comprising:
a housing forming a motor chamber adjacent a pump chamber;
the motor chamber having an outlet for communication with a fluid collection device and a source of aspiration, and an inlet for communication with an aspiration line through which fluids from the surgical site are delivered to the motor chamber;
the pump chamber having an outlet for communication with an infusion line for supplying fluid to the surgical site, and an inlet for communication with a source of infusion fluid;
a first motor rotor and a second motor rotor rotatably disposed within the motor chamber, and positioned in an aspiration flow path between the motor chamber inlet and outlet in the motor chamber, wherein the first and second motor rotors are positioned relative to each other such that at least one blade of both motor rotors overlap in a region of the aspiration flow path;
a first pump rotor and a second pump rotor rotatably disposed within the pump chamber, and positioned in an infusion flow path between the pump chamber inlet and the outlet, wherein the first and second pump rotors are positioned relative to each other such that at least one blade of both pump rotors overlap in a region of the infusion path;
a drive shaft having a first end coupled to the first motor rotor and a second end coupled to the first pump rotor; and
wherein fluid flowing between the inlet and outlet of the motor chamber causes the first motor rotor to rotate the drive shaft, whereby the drive shaft drives the first pump rotor at the same rotational speed as the first motor rotor such that any surge in aspiration fluid flow through the motor chamber induces a similar surge in infusion fluid flow to the operative site, to thereby reduce the risk of surge-induced pressure changes in the operative site.
2. The flow control device of claim 1, wherein the drive shaft drives the first pump rotor at the same rotational speed as the first motor rotor such that any decrease in aspiration fluid flow through the motor chamber induces a similar decrease in infusion fluid flow to the operative site.
3. The flow control device of claim 1, wherein the first and second motor rotors are arranged generally parallel with the first and second pump rotors.
4. The flow control device of claim 3, wherein the first motor rotor and first pump rotor are axially aligned, and the second motor rotor and second pump rotor are axially aligned.
5. The flow control device of claim 4, wherein the motor rotors and pump rotors are comprised of a generally paddle-wheel shaped configuration.
6. The flow control device of claim 4, wherein the overlap between first motor rotor blades and second motor rotor blades results in the first and second motor rotors rotating at substantially the same rotational speed.
7. The flow control device of claim 4, wherein the overlap between first pump rotor blades and second pump rotor blades results in the first and second pump rotors rotating at substantially the same rotational speed.
8. The flow control device of claim 4, wherein the motor rotors extract energy from the fluid flowing between the inlet and outlet of the motor chamber, to thereby rotate the drive shaft.
9. The flow control device of claim 1, wherein the inlet and outlet to the motor chamber and the inlet and outlet to the pump chamber further comprise a tubing barb configured for connection to surgical tubing.
10. A flow control device for balancing fluid flow into and out of a surgical site, comprising:
a housing having a motor chamber disposed therein, and a pump chamber disposed therein adjacent to the motor chamber;
the motor chamber having an outlet for communication with a fluid collection device, and an inlet in communication with an aspiration line through which fluids from a surgical site are delivered to the motor chamber;
the pump chamber having an outlet for communication with an infusion line for supplying fluid to a surgical site, and an inlet through which infusion fluids are delivered to the pump chamber;
a first motor rotor and a second motor rotor rotatably disposed within the motor chamber, and positioned in a flow path between the inlet and the outlet in the motor chamber;
a first pump rotor and a second pump rotor rotatably disposed within the pump chamber, and positioned in a flow path between the inlet and the outlet in the pump chamber;
a first drive shaft having a first end coupled to the first motor rotor and a second end coupled to the first pump rotor;
a second drive shaft having a first end coupled to the second motor rotor and a second end coupled to the second pump rotor; and
wherein fluid flowing between the inlet and outlet of the motor chamber causes the first and second motor rotors to rotate the first and second drive shafts, whereby each drive shaft drives one of the pump rotors at the same rotational speed as a respectively coupled motor rotor, such that any surge in aspiration fluid flow through the motor chamber induces a similar surge in infusion fluid flow through the pump chamber, to thereby reduce the risk of surge-induced pressure changes in the surgical site.
11. The flow control device of claim 10, wherein the first drive shaft drives the first pump rotor at the same rotational speed as the first motor rotor such that any decrease in aspiration fluid flow through the motor chamber induces a similar decrease in infusion fluid flow to the operative site.
12. The flow control device of claim 10, wherein the first and second motor rotors are arranged generally parallel with the first and second pump rotors.
13. The flow control device of claim 12, wherein the first motor rotor and first pump rotor are axially aligned, and the second motor rotor and second pump rotor are axially aligned.
14. The flow control device of claim 13, wherein the motor rotors and pump rotors are comprised of a generally paddle-wheel shaped configuration.
15. The flow control device of claim 13, wherein an overlap between first motor rotor blades and second motor rotor blades results in the first and second motor rotors rotating at substantially the same rotational speed.
16. The flow control device of claim 13, wherein an overlap between first pump rotor blades and second pump rotor blades results in the first and second pump rotors rotating at substantially the same rotational speed.
17. The flow control device of claim 10, wherein the inlet and outlet to the motor chamber and the inlet and outlet to the pump chamber further comprise a tubing barb configured for connection to surgical tubing.
US12/332,782 2008-12-11 2008-12-11 Device for controlling flow rate of aspirated fluids Expired - Fee Related US7819837B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US12/332,782 US7819837B2 (en) 2008-12-11 2008-12-11 Device for controlling flow rate of aspirated fluids
EP09771819.1A EP2379029B1 (en) 2008-12-11 2009-12-08 Device for controlling flow rate of aspirated fluids
HK12101494.5A HK1160758B (en) 2008-12-11 2009-12-08 Device for controlling flow rate of aspirated fluids
CA2745217A CA2745217C (en) 2008-12-11 2009-12-08 Device for controlling flow rate of aspirated fluids
PCT/US2009/067065 WO2010068611A1 (en) 2008-12-11 2009-12-08 Device for controlling flow rate of aspirated fluids
ES09771819T ES2406806T3 (en) 2008-12-11 2009-12-08 Device to control the flow of aspirated fluids
CN2009801499048A CN102245140B (en) 2008-12-11 2009-12-08 Device for controlling flow rate of aspirated fluids
JP2011540812A JP2012511957A (en) 2008-12-11 2009-12-08 Device for controlling the flow rate of aspirated fluid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/332,782 US7819837B2 (en) 2008-12-11 2008-12-11 Device for controlling flow rate of aspirated fluids

Publications (2)

Publication Number Publication Date
US20100152656A1 US20100152656A1 (en) 2010-06-17
US7819837B2 true US7819837B2 (en) 2010-10-26

Family

ID=41682457

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/332,782 Expired - Fee Related US7819837B2 (en) 2008-12-11 2008-12-11 Device for controlling flow rate of aspirated fluids

Country Status (7)

Country Link
US (1) US7819837B2 (en)
EP (1) EP2379029B1 (en)
JP (1) JP2012511957A (en)
CN (1) CN102245140B (en)
CA (1) CA2745217C (en)
ES (1) ES2406806T3 (en)
WO (1) WO2010068611A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10398595B2 (en) 2013-06-04 2019-09-03 Novartis Ag Cyclic aperture flow regulator system
CN103356327B (en) * 2013-07-24 2015-05-13 王进 Flow regulator for ophthalmic phacoemulsification instrument
KR101497465B1 (en) * 2013-07-25 2015-03-02 삼성중공업 주식회사 Sea floor setup structure
JP6574170B2 (en) * 2013-10-31 2019-09-11 ノバルティス アーゲー Cycle aperture flow regulator system
US9610402B2 (en) 2014-03-24 2017-04-04 Medtronic Minimed, Inc. Transcutaneous conduit insertion mechanism with a living hinge for use with a fluid infusion patch pump device
US9770541B2 (en) * 2014-05-15 2017-09-26 Thermedx, Llc Fluid management system with pass-through fluid volume measurement
US20200324040A1 (en) * 2019-04-09 2020-10-15 Covidien Lp Vacuum driven suction and irrigation system
EP3989795A1 (en) 2019-06-27 2022-05-04 Boston Scientific Scimed, Inc. Detection of an endoscope to a fluid management system
CN113730673B (en) * 2021-09-10 2022-06-07 连云港市第一人民医院 Drainage device for medical oncology

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601313A2 (en) 1992-11-06 1994-06-15 GRIESHABER & CO. AG SCHAFFHAUSEN Device for microsurgery on the eye of a living creature
US5499969A (en) 1992-02-05 1996-03-19 Nestle S.A. Microsurgical cassette
US5562612A (en) 1995-02-02 1996-10-08 Charles D. Kelman Apparatus and method for reverse flow irrigation and aspiration of interior regions of the human eye
US5685821A (en) * 1992-10-19 1997-11-11 Arthrotek Method and apparatus for performing endoscopic surgical procedures
US20040039351A1 (en) 2002-06-07 2004-02-26 Barrett Graham D. Flow adaptive aspiration tubing and devices
US6719011B2 (en) 2002-07-01 2004-04-13 Bausch & Lomb Incorporated Turbine fluid flow resistor
US6752795B2 (en) 2002-06-24 2004-06-22 Bausch & Lomb Incorporated Adjustable fluid flow resistor cassette
US20040193099A1 (en) * 2001-07-17 2004-09-30 Macmahon John M. Fluid exchange system for controlled and localized irrigation and aspiration
US20050118048A1 (en) 2003-06-06 2005-06-02 Traxinger Samuel D. Fluid-flow cassette for an ophthalmic surgical instrument
US20060135974A1 (en) 2004-12-20 2006-06-22 Perkins James T Surge dampening irrigation-aspiration tubing
US7217257B2 (en) 2002-09-30 2007-05-15 Bausch & Lomb Incorporated Aspiration flow resistor
US20080294095A1 (en) 2007-05-26 2008-11-27 Jaime Zacharias Outflow rate regulator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85204507U (en) * 1985-04-01 1987-11-18 中国有色金属工业总公司第五建设公司职工医院 Synchronous injection-suck device for ophthalmic operation
CN2148574Y (en) * 1992-07-11 1993-12-08 魏炳生 Medical fluid aspirator
US6599277B2 (en) * 2001-11-30 2003-07-29 Bausch & Lomb Incorporated Aspiration flow meter and control
US20080147023A1 (en) * 2006-12-18 2008-06-19 Mark Alan Hopkins System and method for controlling fluid flow in an aspiration chamber

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5499969A (en) 1992-02-05 1996-03-19 Nestle S.A. Microsurgical cassette
US5685821A (en) * 1992-10-19 1997-11-11 Arthrotek Method and apparatus for performing endoscopic surgical procedures
EP0601313A2 (en) 1992-11-06 1994-06-15 GRIESHABER & CO. AG SCHAFFHAUSEN Device for microsurgery on the eye of a living creature
US5562612A (en) 1995-02-02 1996-10-08 Charles D. Kelman Apparatus and method for reverse flow irrigation and aspiration of interior regions of the human eye
US20040193099A1 (en) * 2001-07-17 2004-09-30 Macmahon John M. Fluid exchange system for controlled and localized irrigation and aspiration
US20040039351A1 (en) 2002-06-07 2004-02-26 Barrett Graham D. Flow adaptive aspiration tubing and devices
US6752795B2 (en) 2002-06-24 2004-06-22 Bausch & Lomb Incorporated Adjustable fluid flow resistor cassette
US6719011B2 (en) 2002-07-01 2004-04-13 Bausch & Lomb Incorporated Turbine fluid flow resistor
US7217257B2 (en) 2002-09-30 2007-05-15 Bausch & Lomb Incorporated Aspiration flow resistor
US20050118048A1 (en) 2003-06-06 2005-06-02 Traxinger Samuel D. Fluid-flow cassette for an ophthalmic surgical instrument
US20060135974A1 (en) 2004-12-20 2006-06-22 Perkins James T Surge dampening irrigation-aspiration tubing
US20080294095A1 (en) 2007-05-26 2008-11-27 Jaime Zacharias Outflow rate regulator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
International Search Report (PCTISA/210) and Written Opinion (PCT/ISA/237) mailed on Mar. 3, 2010.

Also Published As

Publication number Publication date
US20100152656A1 (en) 2010-06-17
WO2010068611A1 (en) 2010-06-17
CN102245140B (en) 2013-10-30
EP2379029B1 (en) 2013-05-01
CN102245140A (en) 2011-11-16
EP2379029A1 (en) 2011-10-26
ES2406806T3 (en) 2013-06-10
HK1160758A1 (en) 2012-08-17
CA2745217A1 (en) 2010-06-17
CA2745217C (en) 2013-10-29
JP2012511957A (en) 2012-05-31

Similar Documents

Publication Publication Date Title
US7819837B2 (en) Device for controlling flow rate of aspirated fluids
JP6912624B2 (en) Selectively movable valve elements for suction and irrigation circuits
JP7048512B2 (en) Ultrasonic lens emulsification suction handpiece with flexible impeller pump
CA2696344C (en) Systems and methods for phacoemulsification with vacuum based pumps
CN101903052B (en) Surgical system with vacuum pump stop
US12076274B2 (en) Aspiration bypass control in a phacoemulsification probe
TW201630628A (en) Quick-opening vent valve for phaco fluidics aspiration system
EP2922482A1 (en) Medical pump
CN105407843A (en) Cyclic aperture flow regulator system
HK1160758B (en) Device for controlling flow rate of aspirated fluids
RU2773370C2 (en) Selectively movable valves for aspiration and irrigation circuits

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED,NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MUSIC, DOUGLAS E.;REEL/FRAME:022573/0231

Effective date: 20090106

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MUSIC, DOUGLAS E.;REEL/FRAME:022573/0231

Effective date: 20090106

AS Assignment

Owner name: CREDIT SUISSE AG, AS ADMINISTRATIVE AGENT, NEW YOR

Free format text: SECURITY AGREEMENT;ASSIGNORS:WP PRISM INC.;BAUSCH & LOMB INCORPORATED;REEL/FRAME:025990/0222

Effective date: 20110308

AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH;REEL/FRAME:028726/0142

Effective date: 20120518

AS Assignment

Owner name: CITIBANK N.A., AS ADMINISTRATIVE AGENT, DELAWARE

Free format text: SECURITY AGREEMENT;ASSIGNORS:BAUSCH & LOMB INCORPORATED;EYEONICS, INC.;REEL/FRAME:028728/0645

Effective date: 20120518

AS Assignment

Owner name: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.), NEW YORK

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:CITIBANK N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:030995/0444

Effective date: 20130805

Owner name: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.),

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:CITIBANK N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:030995/0444

Effective date: 20130805

Owner name: ISTA PHARMACEUTICALS, NEW YORK

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:CITIBANK N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:030995/0444

Effective date: 20130805

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:CITIBANK N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:030995/0444

Effective date: 20130805

AS Assignment

Owner name: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:BAUSCH & LOMB INCORPORATED;REEL/FRAME:031156/0508

Effective date: 20130830

Owner name: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL

Free format text: SECURITY AGREEMENT;ASSIGNOR:BAUSCH & LOMB INCORPORATED;REEL/FRAME:031156/0508

Effective date: 20130830

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20141026

AS Assignment

Owner name: BARCLAYS BANK PLC, AS SUCCESSOR AGENT, NEW YORK

Free format text: NOTICE OF SUCCESSION OF AGENCY;ASSIGNOR:GOLDMAN SACHS LENDING PARTNERS, LLC;REEL/FRAME:034749/0689

Effective date: 20150108

AS Assignment

Owner name: 1530065 B.C. LTD., CANADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: 1261229 B.C. LTD., CANADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: VRX HOLDCO LLC, NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: V-BAC HOLDING CORP., CANADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: SOLTA MEDICAL DUTCH HOLDINGS B.V., NETHERLANDS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.), POLAND

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: ORAPHARMA, INC., NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.), POLAND

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC., CANADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH US, LLC, NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA), POLAND

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC), HUNGARY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH HOLDCO LIMITED, IRELAND

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH COMPANIES INC., CANADA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH AMERICAS, INC., NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH+LOMB OPS B.V., NETHERLANDS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH & LOMB MEXICO, S.A. DE C.V., MEXICO

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: SOLTA MEDICAL IRELAND LIMITED, IRELAND

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: HUMAX PHARMACEUTICAL S.A., COLOMBIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: MEDICIS PHARMACEUTICAL CORPORATION, NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: SANTARUS, INC., NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: SALIX PHARMACEUTICALS, LTD, NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: SALIX PHARMACEUTICALS, INC., NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED), IRELAND

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: PRECISION DERMATOLOGY, INC., NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408

Owner name: SOLTA MEDICAL, INC., NEW JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BARCLAYS BANK PLC, AS COLLATERAL AGENT;REEL/FRAME:070778/0199

Effective date: 20250408